Advanced Delivery Systems and Novel Psilocin Derivatives for Enhanced Therapeutic Applications.
ACS medicinal chemistry letters – December 12, 2024
Source: PubMed
Summary
Scientists have discovered innovative ways to enhance the therapeutic benefits of psilocin, the active compound in "magic mushrooms." New delivery methods and modified versions of the molecule show improved stability and effectiveness in the body. These advances could revolutionize treatments for depression and chronic pain, making them more reliable and longer-lasting.
Abstract
Psychedelic compounds, particularly psilocybin and psilocin, have shown significant therapeutic potential in treating neurological and psychiatric disorders. However, their bioavailability, rapid metabolism, and stability challenges have limited their clinical use. This Patent Highlight reviews recent innovations in psychedelic drug delivery systems and the development of psilocin analogs aimed at improving their pharmacokinetic and pharmacodynamic profiles. Three patents-focused on controlled-release delivery systems, ester analogs, and acetal/ketal derivatives-present novel approaches to enhancing the stability, bioavailability, and efficacy of psilocin and related compounds. These advancements promise more effective treatments for conditions such as depression, chronic pain, and neurodegenerative diseases.